Literature DB >> 11486304

Clinical presentations of soft-tissue infections and surgical site infections.

R L Nichols1, S Florman.   

Abstract

Skin and soft-tissue infections that usually follow minor traumatic events or surgical procedures are caused by a wide spectrum of bacteria. Less frequently, the infections occur spontaneously, which often is clinically confusing and leads to delays in diagnosis. Most of the infections are self-limited and easily treated with local measures and/or antibiotics. Others are life-threatening, requiring prompt diagnosis and aggressive surgical debridement in addition to the wise choice of antibiotic agents to limit tissue loss and preserve life. Many survivors experience critical tissue losses that may require changes in lifestyle as well as major reconstructive cosmetic surgery. Involvement of antibiotic-resistant gram-positive microorganisms in these infections only increases the difficulty of their treatment and may have a significant influence on the ultimate outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486304     DOI: 10.1086/321862

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

2.  CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.

Authors:  H David Friedland; Tanya O'Neal; Donald Biek; Paul B Eckburg; Douglas R Rank; Lily Llorens; Alex Smith; Gary W Witherell; Joseph B Laudano; Dirk Thye
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

3.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

4.  Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Authors:  John Weigelt; Kamal Itani; Dennis Stevens; William Lau; Matthew Dryden; Charles Knirsch
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 5.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Empirical antibiotics use in soft tissue infections.

Authors:  Rodger Shortt; Achilleas Thoma
Journal:  Can J Plast Surg       Date:  2008

7.  The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary study.

Authors:  Ji-Hee Hwang; Ju-Hyung Lee; Mi-Kyoung Moon; Ju-Sin Kim; Kyoung-Suk Won; Chang-Seop Lee
Journal:  Infect Chemother       Date:  2013-03-29

8.  Cellulitis of the right thigh, with gas.

Authors:  F M Braeunling; P M Mackey; C Wright; O E Klimach; D N Ramanaden
Journal:  J R Soc Med       Date:  2003-11       Impact factor: 18.000

Review 9.  Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.

Authors:  Christian Eckmann; M Dryden
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

Review 10.  Chinese herbal medicines for treating skin and soft-tissue infections.

Authors:  Yun Fei Wang; Hua Fa Que; Yong-Jun Wang; Xue Jun Cui
Journal:  Cochrane Database Syst Rev       Date:  2014-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.